Document is current
Any future updates will be listed below
-
Authors
Szekely, Gabriella
Voskanyan, Lilit A. https://orcid.org/0000-0003-2829-9561
Stephens, Kerry G.
Doan, Long V. https://orcid.org/0009-0008-0572-2236
Seal, Jennifer R.
ElMallah, Mohammed K.
Fjield, Todd
Applegate, David
Usner, Dale W. https://orcid.org/0000-0002-2799-0652
Katz, L. Jay
Kothe, Angela C. https://orcid.org/0009-0000-7971-5292
Navratil, Tomas https://orcid.org/0009-0007-3577-3096
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06582732 at ClinicalTrials.govDocuments that mention this clinical trial
Aqueous Humor Concentrations of Travoprost Free Acid and Residual Drug in Explanted Implants from Patients Administered a Travoprost Intracameral Implant
https://doi.org/10.1007/s40123-025-01130-1
- License Information
-
More Information
Article History
Received: 30 January 2025
Accepted: 10 March 2025
First Online: 24 March 2025
Declarations
:
: Gabriella Szekely, Kerry G Stephens, Long V Doan, Jennifer R Seal, Todd Fjield, David Applegate, Dale W Usner, L Jay Katz, Angela C Kothe, and Tomas Navratil are employees of Glaukos and may hold open stock and/or stock options. Lilit A Voskanyan received research funding from Glaukos Corporation for the conduct of the study. Mohammed E ElMallah has received research funding from Glaukos Corporation and New World Medical.
: The study was performed in accordance with International Council on Harmonisation good clinical practices, the tenets of the Declaration of Helsinki, and regulations governing clinical trials in Armenia, and with approval of the relevant institutional review board/independent ethics committee (Ethics Committee of Ophthalmological Center named after S.V. Malayan, Yerevan, Armenia 0048; approval date: 21 December 2019). Written informed consent was obtained from all patients prior to undertaking any study-related procedures.
